Showing 106,061 - 106,080 results of 125,024 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (mean decrease)) ))', query time: 1.34s Refine Results
  1. 106061

    Supplementary file 1_Persistent burden and health inequalities of disease in women of childbearing age attributable to Intimate Partner Violence, 1990–2021.docx by Yingda Song (15410321)

    Published 2025
    “…Aims<p>Intimate Partner Violence (IPV) presents a significant global public health issue, particularly affecting women of childbearing age (WBCA). …”
  2. 106062

    Magnetism and Colossal Magnetoresistance of the Pseudo-Ternary Rare-Earth Transition-Metal Compounds, Eu<sub>14</sub><sub>-</sub><i><sub>x</sub></i>Ca<i><sub>x</sub></i>MnSb<sub>11... by Hyungrak Kim (2953500)

    Published 2001
    “…The rare-earth transition-metal compounds crystallize in the tetragonal space group <i>I</i>4<sub>1</sub>/<i>acd</i>, <i>Z</i> = 8, <i>T</i> = 90 K, <i>a</i> = 17.2235(7) and <i>c</i> = 22.6555(9) Å, <i>V</i> = 6720.7(5) Å<sup>3</sup>, and <i>R</i><i><sub>1</sub></i>/<i>wR</i><i><sub>2</sub></i> (0.0413/0.1129) for <i>x</i> = 1.45 and <i>a</i> = 17.1737(7) and <i>c</i> = 22.5741(10) Å, <i>V</i> = 6657.9(5) Å<sup>3</sup>, and <i>R</i><i><sub>1</sub></i>/<i>wR</i><i><sub>2</sub></i> (0.0392/0.1122) for <i>x</i> = 2.83. …”
  3. 106063

    Effect of Artemisia apiacea Hance on growth performance, cecal opportunistic bacteria, and microbicidal peptides in rabbits by Ke Ding (309244)

    Published 2019
    “…For cecal opportunistic pathogenic bacteria, compared with the control treatment, the herb decreased cecal C. perfringens, Gram-negative bacteria, and Salmonella spp. by 9.5 to 56.8%. …”
  4. 106064

    Enzyme linked immunosorbent assay. by Muthu K. Shanmugam (329744)

    Published 2013
    “…DLP tumor tissues, embedded in paraffin blocks, were cut into 5 µM tissue sections and probed for cyclin D1, caspase 3 and COX-2 immunoreactivities as described in the <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0032476#s4" target="_blank">Materials and Methods</a>. …”
  5. 106065

    Optic nerve stimulation produces fast excitation and slow inhibition in retinal ganglion cell firing activity. by Anastasiia Vlasiuk (11172471)

    Published 2021
    “…<p>(A) Schematic diagram of the experiment. The tip of the optic nerve emerging from an isolated retina was electrically stimulated with a suction electrode (inter-stimulus interval, 1–1.5 s), while a population of ganglion cells was simultaneously recorded with a multi-electrode array (see panel B for example). …”
  6. 106066

    Frequency of Up states depends on the strength of the noise and the cost on spiking. by Veronika Koren (3691690)

    Published 2017
    “…<p>A: In a network with no noise and with linear cost at zero, but with quadratic cost at <i>μ</i> = 5, short but strong Up states regularly appear in the active state. …”
  7. 106067

    Defective expression of <i>Foxa2</i> and <i>Gsc</i> at the late streak stage of ethanol-treated <i>Cdon<sup>−/−</sup></i> embryos. by Mingi Hong (129953)

    Published 2012
    “…<i>Cdon</i> expression was also monitored via ß-galactosidase (ß-gal) activity derived from a <i>LacZ</i> reporter knocked into the <i>Cdon</i> locus in mutant E7.5 embryos (O) at the early bud stage; a wild-type embryo stained for ß-gal activity is shown as a negative control (N). …”
  8. 106068

    Proportional distribution of mutated and ambiguous mutated amino acids at HIVDR sites. by Du-Ping Zheng (40489)

    Published 2013
    “…The scores were summed by 1 for a pure amino acid mutation and 0.5 for an ambiguous amino acid mutation, and then converted to percentages against the total number of wild-type amino acids at the site. …”
  9. 106069

    Model Predictions. by Carmen Pin (113170)

    Published 2012
    “…C) The time for the propagation of a mutation to the stem cell compartment is shorter when the mutation decreases the duration of the division cycle. …”
  10. 106070

    Early Fumagillin Treatment is Associated with Growth in Monocrotaline-Injured Rats. by Daniel J. Kass (173086)

    Published 2012
    “…At weeks 1–4, all MCT-injured animals gained weight at a similar rate (A). Panel (B) represents the data shown in panel (A) at week 5. …”
  11. 106071

    One-parameter bifurcation diagrams for the DA neuron and the HH neuron. by Andrey Dovzhenok (311885)

    Published 2013
    “…Parameters are from C), except that the K<sup>+</sup> current half-activation is decreased by 5 mV (<i>v</i><sub>nh</sub> = −58 mV). …”
  12. 106072

    LDLC estimation database.xlsx by Ion Bogdan Manescu (18891694)

    Published 2024
    “…All equations increasingly underestimated LDLC as dLDLC levels decreased. �lta of the Martin-Hopkins equation showed significant positive correlations with dLDLC (≤130mg/dL) and triglycerides, and a significant negative correlation with HDLC. …”
  13. 106073

    Suppression of NF-κB signaling in <i>Iqgap2</i><sup><i>-/-</i></sup> colons. by Amr M. Ghaleb (668342)

    Published 2015
    “…<p><b>A.</b> IHC shows decreased baseline levels of p65 subunit of NF-κB in <i>Iqgap2</i><sup><i>-/-</i></sup> colon compared to WT (panels a, d). …”
  14. 106074

    Effects of lipid raft perturbation on Dectin-1 dynamics during phagocytosis. by Valeria de Turris (825676)

    Published 2015
    “…The resulting effect of these events was a severely decreased phagocytosis. See also Supplementary <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0142531#pone.0142531.s002" target="_blank">S2</a> and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0142531#pone.0142531.s003" target="_blank">S3</a> Movies.…”
  15. 106075
  16. 106076

    Morpholino knockdown of <i>hjv</i> results in notochord and somite abnormalities. by Yann Gibert (232725)

    Published 2011
    “…Somites (arrows) in uninjected (<b>H</b>) and control morpholino-injected embryos (<b>I</b>) appeared V-shaped, while somites appeared U-shaped with decreased anterior-posterior dimension (distance between each pair of arrows) in <i>hjv</i> morphants (<b>J</b>). …”
  17. 106077

    PCR and WB of KLF8 after shRNA knockdown in U87-MG. by Oliver Schnell (187202)

    Published 2012
    “…(B) Subsequent Western Blot analysis of the nuclear fraction of KLF8-kd U87-MG cells on day 4 after seeding revealed that KLF8 protein was still detectable in all transfected U87-MG cells but only to a small extent in the KLF8-knockdown cells indicating that shRNA-knockdown was successful in these transfected cells in concordance with the qPCR results (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0030429#pone-0030429-g005" target="_blank">Figure 5A</a>).…”
  18. 106078

    Retreatment status in the 2+L cohort. by Shinsuke Iida (385074)

    Published 2025
    “…Retreatment with lenalidomide-, daratumumab-, and isatuximab-based therapy occurred in 44.1%, 35.2%, and 5.6% of patients, respectively.</p><p>Conclusion</p><p>The high use of lenalidomide and DRd in 1L, and high rates of retreatment with lenalidomide and anti-CD38 mAbs in 2L+ indicate a substantial need for new treatment modalities that can be used in 2L+ patients who previously received lenalidomide with/without an anti-CD38 mAb therapy.…”
  19. 106079

    Proline utilization is influenced by carbon source but not by NCR. by Fitz Gerald S. Silao (138169)

    Published 2019
    “…Respiratory growth predominates as glucose level decreases. WT cells were diluted to OD<sub>600</sub> of 0.5 in pre-warmed synthetic proline media containing 10 mM proline (YNB+Pro+BCP) and the indicated levels of glucose with the initial pH adjusted to 6.0. …”
  20. 106080

    Attrition of the study sample. by Shinsuke Iida (385074)

    Published 2025
    “…Retreatment with lenalidomide-, daratumumab-, and isatuximab-based therapy occurred in 44.1%, 35.2%, and 5.6% of patients, respectively.</p><p>Conclusion</p><p>The high use of lenalidomide and DRd in 1L, and high rates of retreatment with lenalidomide and anti-CD38 mAbs in 2L+ indicate a substantial need for new treatment modalities that can be used in 2L+ patients who previously received lenalidomide with/without an anti-CD38 mAb therapy.…”